Digital pathology company Proscia has raised $23 million in a series B financing round, bringing its total funding to $35 million.
The company said it plans to use the new funding to accelerate global development and the reach of its Concentriq software program, ramping up sales and marketing and satisfying increasing demand for digital pathology solutions.